Connect with Cromos Pharma at 40th JP Morgan Healthcare Conference

Meet with Cromos Pharma during the 40th JP Morgan Healthcare Conference, January 2022. Cromos Pharma is delighted to be participating again at this prestigious invite-only event.
Meet with Cromos Pharma during the 40th JP Morgan Healthcare Conference, January 2022. Cromos Pharma is delighted to be participating again at this prestigious invite-only event.

LET OUR EXPERIENCE BENEFIT YOUR NEXT CLINICAL PROGRAM

Our mission is to support our partners in advancement of their clinical development programs that to improve the lives of the patients around the world.

We look forward to sharing with you the advantages of partnering with Cromos Pharma including:

  • International expertise combined with in-depth regional knowledge in Central and Eastern Europe (300+ clinical trials conducted in 70+ indications).
  • Extensive PI/site and patient network (40,000+ patients enrolled from nearly 2,500 trial sites).
  • Unparalleled patient recruitment – our team met or shortened project timelines in 95% of conducted trials.
  • Extremely short startup timelines (e.g. Georgia where we assure a study launch in less than 2 months).
  • Expertise in innovative, generics and biosimilar global studies (NDAs, ANDAs, BLAs, 505b2).
  • Regulatory inspections and audits that attest to the highest quality of data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection).
  • Clinical Development Strategy – we provide expert guidance on study design, favorable venues, local and global landscape to improve study outcomes.

You can also find out more about availing of Cromos Pharma’s special programs including:

FREE FEASIBILITY REPORTS

Free Feasibility Reports for sponsors considering expanding their clinical trials into Central and Eastern Europe. You confidentially provide us with your protocol, synopsis, or trial outline and in just two weeks our expert team will deliver a detailed feasibility report including:

  • Competitive landscape
  • Review of local standards of care
  • Historical recruitment statistics
  • Regulatory requirements and timelines
  • Realistic recruitment projections

NO PATIENTS – NO PAYMENT

“No Patients – No Payment” is Cromos Pharma’s proprietary risk sharing program through which we give our assurance that your enrollment goals, budgets, and timelines will be met.  Simply put, if we don’t recruit – you don’t pay.

ABOUT CROMOS PHARMA

Cromos Pharma is a US-based international contract research organization with 16 years of experience in delivering fully integrated clinical research solutions in all aspects of clinical trials in all clinical phases across a wide range of therapeutic areas. Our expert team boasts wide-ranging expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management. From biosimilars and generics to successfully managing oncology, neurology, dermatology clinical trials our team provides full service solutions to international pharma and biotech in high recruiting regions with high quality data assured. Established in 2004, Cromos Pharma has strong regional experience in Central and Eastern Europe supported by an extensive network of offices. Its international HQ is in Portland, Oregon, USA and EU HQ in Dublin, Ireland.

CONTACT US TODAY TO ARRANGE A MEETING BD@CROMOSPHARMA.COM

CONTACT

BD@CROMOSPHARMA.COM

To arrange an introductory meeting and find out how our experience can benefit your next clinical project.